N-myristoyltransferase inhibitors as new leads to treat sleeping sickness
N-myristoyltransferase inhibitors as new leads to treat sleeping sickness is a paper indexed in ScholarIQ from OpenAlex.
How many citations does N-myristoyltransferase inhibitors as new leads to treat sleeping sickness have?
N-myristoyltransferase inhibitors as new leads to treat sleeping sickness has 314 citations in the OpenAlex counts ScholarIQ stores.
When was N-myristoyltransferase inhibitors as new leads to treat sleeping sickness published?
N-myristoyltransferase inhibitors as new leads to treat sleeping sickness has 2010 year in the ScholarIQ index.
What is the open-access status of N-myristoyltransferase inhibitors as new leads to treat sleeping sickness?
N-myristoyltransferase inhibitors as new leads to treat sleeping sickness has green oa status in the ScholarIQ index.
What is the DOI of N-myristoyltransferase inhibitors as new leads to treat sleeping sickness?
The DOI for N-myristoyltransferase inhibitors as new leads to treat sleeping sickness is on the source record.
What is the PMID of N-myristoyltransferase inhibitors as new leads to treat sleeping sickness?
The PMID for N-myristoyltransferase inhibitors as new leads to treat sleeping sickness is on the source record.
What is the OpenAlex record for N-myristoyltransferase inhibitors as new leads to treat sleeping sickness?
The OpenAlex for N-myristoyltransferase inhibitors as new leads to treat sleeping sickness is on the source record.